Authors’ contributions
NCL
All authors participated in the development of the study. BM, JMC, JK, OEL, and TL were site champions for the Prevent CDI-55 + study, and DS and BD were the pharmacist champions. NCL and WO conducted the focus groups. WO coded the information obtained from the focus groups, and JF and JHL assessed coding agreement. LCB created the first draft, and all other authors contributed to the revision of the manuscript. All authors read and approved the final manuscript.